On September 24, 2026, BlackRock, Inc. sold 490,600 shares of HENGRUI PHARMA (01276) on the SEHK open market at an average of HKD 47.4810 per share, involving about HKD 23.29 million. This was an on-exchange active trade, i.e., a direct dealing in the secondary market.
Prior to the disposal, BlackRock, Inc.'s long position in HENGRUI PHARMA was 18.45 million shares, representing 7.15%; following the disposal, the holding changed to 17.96 million shares, with the long position ratio falling to 6.96%.